Skip to main content
OpenTrials
Completed

NCT Number: NCT05642065

Hip Activation and FSDT

The purpose of this study is to determine if activation training of the hip musculature affects muscle activation and frontal plane mechanics in healthy individuals.

Specific Aim 1: Determine whether performance on the forward step-down test (FSDT) changes after an eight-week home exercise program (HEP) focused on hip musculature activation in healthy individuals.

Specific Aim 2: Determine whether surface electromyography (sEMG) hip musculature changes following an eight-week HEP focused on hip musculature activation in healthy individuals.

Specific Aim 3: Determine whether a dose-response relationship exists between compliance on the HEP and changes in FSDT scores in healthy individuals.

Specific Aim 4: Determine whether a dose-response relationship exists between compliance on the HEP and sEMG changes in hip musculature activation in healthy individuals.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Louisiana State University Health Sciences Center - Shreveport

Shreveport, Louisiana, 71130, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be current first or second year Doctor of Physical Therapy students in the School of Allied Health Professions at LSU Health Shreveport.

Exclusion criteria

  • Current knee pain or pathology in the dominant leg, and women with known pregnancy.

Treatment and study plan

Hip muscle activation home exercise program

Other

Participants will perform a home exercise program consisting of five hip muscle activation exercises with the use of a resistance band. The program will be eight weeks in duration, and participants will perform the exercises twice weekly.

Primary outcomes

  1. Scores on the Forward Step Down Test

    Time frame: Pre- and Post- Intervention Program (8 weeks)

    Participants will perform the Forward Step Down Test pre- and post-intervention, while being score by two investigators simultaneously.

Secondary outcomes

  1. Surface electromyography (sEMG) - Gluteus Maximus

    Time frame: Pre- and Post- Intervention Program (8 weeks)

    sEMG data for the gluteus maximus, including both mean EMG activation and peak EMG activation will be recorded during performance of the Forward Step Down Test.

  2. Surface electromyography (sEMG) - Gluteus Medius

    Time frame: Pre- and Post- Intervention Program (8 weeks)

    sEMG data for the gluteus medius, including both mean EMG activation and peak EMG activation will be recorded during performance of the Forward Step Down Test.

  3. Home Exercise Program (HEP) Compliance

    Time frame: Pre- and Post- Intervention Program (8 weeks)

    Participants will complete a log of the number of HEP sessions they complete during the 8-week intervention program. The sum of sessions completed will be used as a measure of compliance.

Sponsors and collaborators

Lead sponsor

Louisiana State University Health Sciences Center Shreveport

Other

Registry information

Official study title

Does a Hip Muscle Activation Home Exercise Program Change Patient Performance on the Forward Step-Down Test? A Single-Arm Clinical Trail

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Dec 8, 2022
Registry last updated
May 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.